The Future of Biotech in DFW

UTA and Texas A&M have partnered to bring a cutting-edge biomanufacturing and precision medicine hub to Pegasus Park in Dallas.

Opened in November 2025, the new satellite campus of the National Center for Therapeutics Manufacturing (NCTM²) provides hands-on training for students and industry partners, state-of-the-art lab space, and support for biotech startups, expanding workforce development and research opportunities in North Texas.

The demand for domestic biomanufacturing capabilities is growing, and UTA and A&M believe this partnership will position North Texas as a leader in the industry. It is part of a larger national effort to strengthen the U.S. bioeconomy and advance domestic production of vaccines, therapeutics, and biopharmaceuticals.